Jemincare
Clinical trials sponsored by Jemincare, explained in plain language.
-
New shot could tame stubborn hives when pills fail
Disease control Not yet recruitingThis study tests an injection called JYB1904 in 180 adults with chronic spontaneous urticaria (hives and itching lasting over 6 weeks) that isn't well controlled by standard antihistamines. Participants receive either the drug or a placebo every 12 weeks for 48 weeks. The main go…
Phase: PHASE3 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New pill takes on hard-to-treat lung cancer in major trial
Disease control Not yet recruitingThis study tests a new targeted drug, JMKX001899, against standard chemotherapy (docetaxel) in people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12C. About 472 adults who have already tried at least one prior treatment will be randoml…
Phase: PHASE3 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New allergy shot for teens enters early safety testing
Symptom relief Not yet recruitingThis early-stage study tests a new injection called JYB1904 in 12 teenagers aged 12-17 with allergies like hay fever, asthma, or food allergies. The main goal is to see if the drug is safe and how the body processes it. Participants will be closely monitored for side effects and …
Phase: PHASE1 • Sponsor: Jemincare • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New shot could quiet constant sniffles for months
Symptom relief Not yet recruitingThis study tests an injection called JYB1904 for people with year-round allergies (perennial allergic rhinitis). The goal is to see if it can reduce symptoms like runny nose, congestion, and sneezing better than a placebo. About 135 adults who already use nasal sprays will receiv…
Phase: PHASE2 • Sponsor: Jemincare • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New drug interaction study launches for polycystic kidney disease treatment
Knowledge-focused Not yet recruitingThis early-stage study tests how a new drug called JMKX003142 interacts with other common medications in 112 healthy Chinese adults. The drug is being developed for autosomal dominant polycystic kidney disease (ADPKD). Researchers will measure how the body processes JMKX003142 wh…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New Drug's heart effects under microscope in early safety trial
Knowledge-focused Not yet recruitingThis early-stage study checks whether a single dose of JMKX003142 affects the heart's electrical activity in 24 healthy Chinese adults. Participants will be randomly assigned to receive the drug or a placebo. The goal is to see if the drug causes any changes in heart rhythm, not …
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Healthy men to help unravel how new kidney drug is processed
Knowledge-focused Not yet recruitingThis phase 1 trial will enroll 8 healthy Chinese men to study how the experimental drug JMKX003142 is absorbed, broken down, and eliminated from the body. Participants will receive the drug in both pill and IV forms, some with a radioactive tracer. The study aims to measure the d…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New kidney drug interaction study launches in healthy volunteers
Knowledge-focused Not yet recruitingThis early-stage study tests how a new drug called JMKX003142 interacts with two common medications—amiodarone (for heart rhythm) and febuxostat (for gout)—in 48 healthy Chinese adults. Participants will take the drugs in sequence to measure how their bodies process them. The goa…
Phase: PHASE1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:26 UTC